论文部分内容阅读
目的:探讨急性呼吸窘迫综合征的重症监护病房(ICU)临床治疗效果。方法:根据发病原因将2012年1月-2015年4月本院收治的30例急性呼吸窘迫综合征患者分为肺外源性组和肺内源性组,给予常规机械通气和乌司他丁注射液治疗后,比较两组患者住ICU时间、机械通气时间、1周内死亡率和住ICU期间总死亡率。结果:肺外源性急性呼吸窘迫患者在住ICU时间、机械通气时间和1周内死亡率上,低于肺内源性急性呼吸窘迫患者(P<0.05);但是总死亡率比较,差异无统计学意义(P>0.05)。结论:急性呼吸窘迫综合征是临床上的一种常见病,死亡率较高,根据发病原因采取对症治疗措施,才能提高患者的存活率。
Objective: To investigate the clinical effect of intensive care unit (ICU) in acute respiratory distress syndrome. Methods: Thirty patients with acute respiratory distress syndrome admitted to our hospital from January 2012 to April 2015 were divided into exogenous lung group and endogenous pulmonary group according to the cause of the disease. The patients were given routine mechanical ventilation and ulinastatin After injection, ICU time, mechanical ventilation time, 1-week mortality and total mortality during ICU stay were compared between the two groups. Results: The exogenous acute respiratory distress patients were lower than the patients with endogenous acute respiratory distress (P <0.05) in the duration of ICU stay, mechanical ventilation time and death within 1 week; however, there was no statistical difference in the total mortality rate Significance (P> 0.05). Conclusion: Acute respiratory distress syndrome is a common clinical disease with high mortality rate. According to the cause of the disease, symptomatic treatment measures can be taken to improve the survival rate of patients.